Oral BGE-102: Clinical Trials

2 trials of Oral BGE-102, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Recruiting 1

Follow Oral BGE-102: new trials by email Literature Review of Oral BGE-102 trials Research Report on Oral BGE-102

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
Oral BGE-102, Oral Placebo Matching BGE-102, Anti-VEGF - Diabetic Macular Edema (DME)
Phase 2RecruitingBioAge Labs, Inc.1802026-08-212026-10-27
A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors
Oral BGE-102, Oral Placebo Matching BGE-102 - Obesity and Cardiovascular Risk
Phase 2Active not recruitingBioAge Labs, Inc.1602026-06-112026-09-10

Conditions studied

Diabetic Retinopathy (1)  ·  Obesity (1)

Sponsors

BioAge Labs, Inc. (2)

Countries

United States (2)  ·  Puerto Rico (1)